Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Tang

Showing results (1601-1610 of 1,689) with videos related to

Pageof 169
Sort By:
Cancer Cell|July 7, 2015
PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical ModelsHelen Y Zou, Luc Friboulet, David P Kodack, et al.
Cell Reports|August 24, 2025
A capsular polysaccharide from a healthy human microbiota member activates a Lag-3-NK cell axis to restrain colon cancer and augment immunotherapyAllison M Weis, Kaylyn M Bauer, William W Tang, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|March 16, 2020
[A pathological report of three COVID-19 cases by minimal invasive autopsies]X H Yao, T Y Li, Z C He, et al.
Environment International|June 11, 2020
How can airborne transmission of COVID-19 indoors be minimised?Lidia Morawska, Julian W Tang, William Bahnfleth, et al.
Journal of Neurosurgery. Pediatrics|January 26, 2024
Repeat stereotactic radiosurgery for persistent cerebral arteriovenous malformations in pediatric patientsGracie Garcia, Georgios Mantziaris, Stylianos Pikis, et al.
Lancet (London, England)|November 6, 2023
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trialBrad H Rovin, Jonathan Barratt, Hiddo J L Heerspink, et al.
Kidney International Reports|December 18, 2023
Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA NephropathyFrederick W K Tam, James Tumlin, Jonathan Barratt, et al.
Plos One|March 6, 2013
An ACACB variant implicated in diabetic nephropathy associates with body mass index and gene expression in obese subjectsLijun Ma, Mariana Murea, James A Snipes, et al.
JAMA|June 5, 2026
Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical TrialBrendon L Neuen, Vlado Perkovic, Rajiv Agarwal, et al.
Kidney International|September 24, 2021
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular DiseasesBrad H Rovin, Sharon G Adler, Jonathan Barratt, et al.
Pageof 169

Showing results (1601-1610 of 1,689) with videos related to

Sort By:
Pageof 169
Cancer Cell|July 7, 2015
PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical ModelsHelen Y Zou, Luc Friboulet, David P Kodack, et al.
Cell Reports|August 24, 2025
A capsular polysaccharide from a healthy human microbiota member activates a Lag-3-NK cell axis to restrain colon cancer and augment immunotherapyAllison M Weis, Kaylyn M Bauer, William W Tang, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|March 16, 2020
[A pathological report of three COVID-19 cases by minimal invasive autopsies]X H Yao, T Y Li, Z C He, et al.
Environment International|June 11, 2020
How can airborne transmission of COVID-19 indoors be minimised?Lidia Morawska, Julian W Tang, William Bahnfleth, et al.
Journal of Neurosurgery. Pediatrics|January 26, 2024
Repeat stereotactic radiosurgery for persistent cerebral arteriovenous malformations in pediatric patientsGracie Garcia, Georgios Mantziaris, Stylianos Pikis, et al.
Lancet (London, England)|November 6, 2023
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trialBrad H Rovin, Jonathan Barratt, Hiddo J L Heerspink, et al.
Kidney International Reports|December 18, 2023
Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA NephropathyFrederick W K Tam, James Tumlin, Jonathan Barratt, et al.
Plos One|March 6, 2013
An ACACB variant implicated in diabetic nephropathy associates with body mass index and gene expression in obese subjectsLijun Ma, Mariana Murea, James A Snipes, et al.
JAMA|June 5, 2026
Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical TrialBrendon L Neuen, Vlado Perkovic, Rajiv Agarwal, et al.
Kidney International|September 24, 2021
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular DiseasesBrad H Rovin, Sharon G Adler, Jonathan Barratt, et al.
Pageof 169